Cargando…

Correction to: Fremanezumab: First Global Approval

Detalles Bibliográficos
Autor principal: Hoy, Sheridan M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6439160/
https://www.ncbi.nlm.nih.gov/pubmed/30859411
http://dx.doi.org/10.1007/s40265-019-01088-y
_version_ 1783407204957683712
author Hoy, Sheridan M.
author_facet Hoy, Sheridan M.
author_sort Hoy, Sheridan M.
collection PubMed
description
format Online
Article
Text
id pubmed-6439160
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Springer International Publishing
record_format MEDLINE/PubMed
spelling pubmed-64391602019-04-15 Correction to: Fremanezumab: First Global Approval Hoy, Sheridan M. Drugs Correction Springer International Publishing 2019-03-11 2019 /pmc/articles/PMC6439160/ /pubmed/30859411 http://dx.doi.org/10.1007/s40265-019-01088-y Text en © Springer Nature 2019 Open AccessThis article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), which permits any noncommercial use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.
spellingShingle Correction
Hoy, Sheridan M.
Correction to: Fremanezumab: First Global Approval
title Correction to: Fremanezumab: First Global Approval
title_full Correction to: Fremanezumab: First Global Approval
title_fullStr Correction to: Fremanezumab: First Global Approval
title_full_unstemmed Correction to: Fremanezumab: First Global Approval
title_short Correction to: Fremanezumab: First Global Approval
title_sort correction to: fremanezumab: first global approval
topic Correction
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6439160/
https://www.ncbi.nlm.nih.gov/pubmed/30859411
http://dx.doi.org/10.1007/s40265-019-01088-y
work_keys_str_mv AT hoysheridanm correctiontofremanezumabfirstglobalapproval